(VIANEWS) - PDC Energy (PDCE), Freeport (FCX), Darling Ingredients (DAR) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. PDC Energy (PDCE)
230.8% sales growth and 18.9% return on equity
PDC Energy, Inc. is an independent exploration company that acquires, investigates, develops, produces and distributes crude oil, natural gases, and natural gas liquids throughout the United States.
PDC Energy's sales growth this year is expected to be 72% and 3.6% for next year.
Year-on-year quarterly revenue growth grew by 141%, now sitting on 2.39B for the twelve trailing months.
Volume
Today's last reported volume for PDC Energy is 220227 which is 86.37% below its average volume of 1616490.
PDC Energy's sales growth for the next quarter is 230.8%. The company's growth estimates for the current quarter and the next is 104.3% and 95.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.9%.
Volatility
PDC Energy's last day, last week, and last month's current intraday variation average was 4.10%, 2.91%, and 2.47%, respectively.
PDC Energy's highest amplitude of average volatility was 3.99% (day), 3.91% (last week), and 4.48% (last month), respectively.
PDC Energy's Stock Yearly Top and Bottom Value
PDC Energy's stock is valued at $74.88 at 20:22 EST, below its 52-week high of $78.13 and way above its 52-week low of $32.17.
PDC Energy's Moving Average
PDC Energy's worth is way higher than its 50-day moving average of $64.06 and way above its 200-day moving average of $51.39.2. Freeport (FCX)
28.3% sales growth and 25.74% return on equity
Freeport's sales growth this year is anticipated to be 62.2% and 9.6% for next year.
Year-on-year quarterly revenue growth grew by 37.1%, now sitting on 22.84B for the twelve trailing months.
Volume
Today's last reported volume for Freeport is 10732800 which is 42.76% below its average volume of 18751200.
Freeport's sales growth for the next quarter is 28.3%. The company's growth estimates for the current quarter and the next is 128.2% and 62.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 25.74%.
Volatility
Freeport's last day, last week, and last month's current intraday variation average was 1.66%, 2.24%, and 1.96%, respectively.
Freeport's highest amplitude of average volatility was 2.53% (day), 4.41% (last week), and 3.91% (last month), respectively.
Freeport's Stock Yearly Top and Bottom Value
Freeport's stock is valued at $49.15 at 20:22 EST, under its 52-week high of $51.99 and way higher than its 52-week low of $30.02.
Freeport's Moving Average
Freeport's value is above its 50-day moving average of $45.78 and way above its 200-day moving average of $39.38.3. Darling Ingredients (DAR)
15.3% sales growth and 20.86% return on equity
Darling Ingredients Inc. produces and sells natural products made from bio-nutrients that are edible or inedible.
Darling Ingredients's sales growth this year is anticipated to be 16.3% and 2.5% for next year.
Year-on-year quarterly revenue growth grew by 28.5%, now sitting on 4.74B for the twelve trailing months.
Volume
Today's last reported volume for Darling Ingredients is 374268 which is 73.46% below its average volume of 1410340.
Darling Ingredients's sales growth for the next quarter is 15.3%. The company's growth estimates for the current quarter and the next is 25.6% and 12%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 20.86%.
Volatility
Darling Ingredients's last day, last week, and last month's current intraday variation average was 0.61%, 1.77%, and 2.04%, respectively.
Darling Ingredients's highest amplitude of average volatility was 4.02% (day), 3.86% (last week), and 3.61% (last month), respectively.
Darling Ingredients's Stock Yearly Top and Bottom Value
Darling Ingredients's stock is valued at $76.65 at 20:22 EST, way under its 52-week high of $85.98 and way higher than its 52-week low of $58.70.
Darling Ingredients's Moving Average
Darling Ingredients's worth is higher than its 50-day moving average of $72.59 and higher than its 200-day moving average of $71.50.4. Cracker Barrel Old Country Store (CBRL)
9.7% sales growth and 23.23% return on equity
Cracker Barrel Old Country Store, Inc. is responsible for the development and operation of the Cracker Barrel Old Country Store concept within the United States.
Cracker Barrel Old Country Store's sales growth this year is anticipated to be 17.1% and 4.4% for next year.
Year-on-year quarterly revenue growth grew by 27.3%, now sitting on 3.15B for the twelve trailing months.
Volume
Today's last reported volume for Cracker Barrel Old Country Store is 211677 which is 41.04% below its average volume of 359053.
Cracker Barrel Old Country Store's sales growth is a negative 0% for the current quarter and 9.7% for the next. The company's growth estimates for the current quarter and the next is a negative 7.3% and 4.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 23.23%.
Volatility
Cracker Barrel Old Country Store's last day, last week, and last month's current intraday variation average was 0.20%, 1.94%, and 2.20%, respectively.
Cracker Barrel Old Country Store's highest amplitude of average volatility was 2.46% (day), 3.15% (last week), and 3.95% (last month), respectively.
Cracker Barrel Old Country Store's Stock Yearly Top and Bottom Value
Cracker Barrel Old Country Store's stock is valued at $115.29 at 20:22 EST, way below its 52-week high of $178.82 and above its 52-week low of $109.51.
Cracker Barrel Old Country Store's Moving Average
Cracker Barrel Old Country Store's value is under its 50-day moving average of $122.16 and way below its 200-day moving average of $133.34.Previous days news about Cracker Barrel Old Country Store(CBRL)
- According to Bloomberg Quint on Thursday, 14 April, "One possible example: Ruth's Hospitality Group Inc. - the operator of the Ruth's Chris steakhouses - has proved much more resilient this year than Denny's Corp. or Cracker Barrel Old Country Store Inc."
5. Johnson & Johnson (JNJ)
8.4% sales growth and 30.41% return on equity
Johnson & Johnson develops, manufactures and markets various products for the global health care industry.
Johnson & Johnson's sales growth this year is anticipated to be 14.2% and 3.9% for next year.
Year-on-year quarterly revenue growth grew by 10.4%, now sitting on 93.78B for the twelve trailing months.
Volume
Today's last reported volume for Johnson & Johnson is 4312560 which is 46.66% below its average volume of 8086120.
Johnson & Johnson's sales growth for the next quarter is 8.4%. The company's growth estimates for the current quarter and the next is 14% and 1.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 30.41%.
Volatility
Johnson & Johnson's last day, last week, and last month's current intraday variation average was 0.18%, 0.88%, and 1.15%, respectively.
Johnson & Johnson's highest amplitude of average volatility was 1.37% (day), 2.03% (last week), and 1.98% (last month), respectively.
Johnson & Johnson's Stock Yearly Top and Bottom Value
Johnson & Johnson's stock is valued at $179.84 at 20:23 EST, below its 52-week high of $183.19 and way higher than its 52-week low of $155.72.
Johnson & Johnson's Moving Average
Johnson & Johnson's value is above its 50-day moving average of $171.67 and above its 200-day moving average of $168.41.Previous days news about Johnson & Johnson(JNJ)
- According to Bloomberg Quint on Tuesday, 12 April, "The exits include Charles Wang, a former Johnson & Johnson executive; as well as James Kretlow, Lawrence Huan, Yaniv Kerem and Bronwyn Harris."
- According to Bloomberg Quint on Tuesday, 12 April, "The exits include Charles Wang, a former Johnson & Johnson executive; as well as James Kretlow, Lawrence Huan, Yaniv Kerem and Bronwyn Harris."
- According to Bloomberg Quint on Tuesday, 12 April, "Representatives of Johnson & Johnson didn't immediately return emails requesting comment."
- According to Bloomberg Quint on Thursday, 14 April, "In the U.S., the club drug and anesthetic ketamine, and a related FDA-approved compound esketamine, developed by Johnson & Johnson as a nasal spray, are already available in such facilities."
- According to Bloomberg Quint on Thursday, 14 April, "The continent's biggest drugmaker is making the doses on behalf of Johnson & Johnson at a plant in South Africa and in March said it agreed to make those shots under its own brand. "